About SkyePharma PLC
Skyepharma Ltd, formerly Skyepharma PLC, is a drug delivery company engaged in the development of oral and inhalation products. The Company operates as an independent developer of complex pharmaceutical products for global markets. Its principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies. It operates through the segment of development and supply of pharmaceutical products. It is also involved in the supply of products to its marketing partners, as in the case for flutiform and over seven oral products manufactured in its Lyon Facility. It operates primarily for respiratory applications. Its inhalation products include Relvar Ellipta/Breo Ellipta, Anoro Ellipta and Incruse Ellipta. Its oral products include RAYOS/LODOTRA, Requip Once-a-day, Xatral/Uroxatral, Madopar DR/Prolopa, Sular, ZYFLO CR, Paxil CR, Diclofenacratiopharm Uno, Triglide and Coruno.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: SKYEY
- Previous Close: $6.28
- 50 Day Moving Average: $6.62
- 200 Day Moving Average: $6.01
- 52-Week Range: $3.95 - $6.97
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $N/A
Consensus Ratings for SkyePharma PLC (NASDAQ:SKYEY) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for SkyePharma PLC (NASDAQ:SKYEY)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for SkyePharma PLC (NASDAQ:SKYEY)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for SkyePharma PLC (NASDAQ:SKYEY)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for SkyePharma PLC (NASDAQ:SKYEY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for SkyePharma PLC (NASDAQ:SKYEY)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for SkyePharma PLC (NASDAQ:SKYEY)
What is SkyePharma PLC's stock symbol?
SkyePharma PLC trades on the NASDAQ under the ticker symbol "SKYEY."
How do I buy SkyePharma PLC stock?
Shares of SkyePharma PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of SkyePharma PLC stock cost?
One share of SkyePharma PLC stock can currently be purchased for approximately $6.28.
SkyePharma PLC (NASDAQ:SKYEY) Chart for Tuesday, February, 28, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart